Menu
Back to Journals » Drug Design, Development and Therapy » Volume 10
Original Research
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 9,255 | Dovepress* | 6,474 | 1,346+ | 1,260 | 7,820 |
| PubMed Central* | 0 | 1,435 | 546 | 1,435 | |
| Totals | 6,474 | 2,781 | 1,806 | 9,255 | |
|
*Since 16 August 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar